B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ionomycin

300 PubMed studies analyzed · 2 RCTs · Evidence Score: 43.4

Research Domains

Ionomycin has been studied across 21 research domains including 🦴 Bone & Joint, 🔬 Oncology, 🔬 Inflammation, 🧠 Focus & Attention, 🛡️ Immunity. The primary research focus is 🦴 Bone & Joint with 64% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ionomycin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.